EcoDrugPlus

Hepatocyte Growth Factor Receptor-Like

Ensembl ID : ENSPFOG00000014285
Gene Symbol: LOC103150629
3 Cross references
205 Possible Orthologues:

High Mobility Group Protein B1-Like

Ensembl ID : ENSPFOG00000004533
Gene Symbol: LOC103140695
3 Cross references
509 Possible Orthologues:

High Mobility Group-T Protein

Ensembl ID : ENSPFOG00000012508
Gene Symbol: LOC103139724
2 Cross references
511 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSPFOG00000020365
Gene Symbol: HRH1
2 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSPFOG00000019178
Gene Symbol: HRH2
3 Cross references
182 Possible Orthologues:

Histamine Receptor H2a

Ensembl ID : ENSPFOG00000006460
Gene Symbol: HRH2A
1 Cross references
189 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSPFOG00000011004
Gene Symbol: HDAC10
1 Cross references
180 Possible Orthologues:

Histone Deacetylase 10-Like

Ensembl ID : ENSPFOG00000010646
Gene Symbol: HDAC10
3 Cross references
180 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSPFOG00000009746
Gene Symbol: HDAC11
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSPFOG00000015383
Gene Symbol: HDAC2
4 Cross references
209 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSPFOG00000003483
Gene Symbol: HDAC3
4 Cross references
155 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSPFOG00000003302
Gene Symbol: HDAC4
1 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).